Efficacy grade | Criteria | No. patients (%) |
---|---|---|
Symptom: Post/pre ratio of IPSS-t | ||
Excellent |  ≤ 0.25 | 161 (39.95) |
Good |  ≤ 0.50 | 146 (36.23) |
Fair |  ≤ 0.75 | 69 (17.12) |
Poor |  > 0.75 | 27 (6.70) |
QoL: Pre-post of QoL index | ||
Excellent | 6,5,4 | 139 (34.49) |
Good | 3 | 125 (31.02) |
Fair | 2,1 | 105 (26.05) |
Poor | 0 | 34 (8.44) |
Function: Post–pre of Qmax | ||
Excellent |  ≥ 10 mL/s | 116 (28.78) |
Good |  ≥ 5 mL/s | 172 (42.68) |
Fair |  ≥ 2.5 mL/s | 77 (19.11) |
Poor |  < 2.5 mL/s | 38 (9.43) |
The overall efficacy: median of efficacy grades of symptom, function and QoL | ||
Excellent | Â | 136 (33.75) |
Good | 161 (39.95) | |
Fair | 84 (20.84) | |
Poor | 22 (5.46) |